Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Korea Business Times.
Press releases published on May 5, 2025
Denver's DUI Law Firm Provides Top-Tier Legal Defense with Client-Focused Approach
GlobeNewswire
·
May 5, 2025
Denver, Colorado, May 05, 2025 (GLOBE NEWSWIRE) -- DUI Law Firm Denver is proud to share its commitment to helping clients through legal challenges, focusing primarily on DUI cases. The firm prides itself on its strong legal foundations and works through …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Landstar System, Inc. – LSTR
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Landstar System, Inc. (“Landstar” or the “Company”) (NASDAQ: LSTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
Derila Ergo Launches Innovative Ergonomic Pillow for Enhanced Comfort
GlobeNewswire
·
May 5, 2025
New York, NY, May 05, 2025 (GLOBE NEWSWIRE) -- Derila Ergo has officially launched its new ergonomic pillow, designed with comfort features that support comfortable sleep positions. With a distinctive butterfly-shaped structure, the Derila Ergo features a …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Senti Biosciences, Inc. – SNTI
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Senti Biosciences, Inc. (“Senti” or the “Company”) (NASDAQ: SNTI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
Camfil USA Addresses Critical Indoor Air Quality Concerns as Wildfire Season Approaches
GlobeNewswire
·
May 5, 2025
Riverdale, NJ, May 05, 2025 (GLOBE NEWSWIRE) -- As wildfire season approaches across North America, Camfil USA air filtration experts are highlighting the importance of preparing indoor environments against smoke contamination. 2025 has already seen …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of T-Mobile US, Inc. – TMUS
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of T-Mobile US, Inc. (“T-Mobile” or the “Company”) (NASDAQ: TMUS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of FTI Consulting, Inc. – FCN
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of FTI Consulting, Inc. (“FTI” or the “Company”) (NYSE: FCN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amerant Bancorp Inc. – AMTB
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amerant Bancorp Inc. (“Amerant” or the “Company”) (NYSE: AMTB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …
OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab
GlobeNewswire
·
May 5, 2025
OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab Lusvertikimab well tolerated over the 24-week additional treatment period. Oral presentation at DDW 2025 of clinical data from …
Five Star Bancorp Expands Food and Agribusiness Vertical
GlobeNewswire
·
May 5, 2025
RANCHO CORDOVA, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a holding company that operates through its wholly owned banking subsidiary, Five Star Bank, has expanded its food and agribusiness …
OSE Immunotherapeutics annonce que plus de 90% des patients répondeurs ont maintenu une rémission symptomatique pendant la période d’extension sous Lusvertikimab
GlobeNewswire
·
May 5, 2025
OSE Immunotherapeutics annonce que plus de 90 % des patients répondeurs ont maintenu une rémission symptomatique pendant la période d’extension sous Lusvertikimab Bonne tolérance de Lusvertikimab pendant les 24 semaines supplémentaires de traitement. …
MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Wabash National Corporation – WNC
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Wabash National Corporation (“Wabash” or the “Company”) (NYSE: WNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Humana Inc. – HUM
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCO
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jack in the Box Inc. - JACK
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Jack in the Box Inc. (“Jack in the Box” or the “Company”) (NASDAQ: JACK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SelectQuote, Inc. - SLQT
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
Transaction in Own Shares
GlobeNewswire
·
May 5, 2025
Transaction in Own Shares 5 May, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 5 May, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVN
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. (“Arvinas” or the “Company”) (NASDAQ: ARVN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581 …
AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual Meeting
GlobeNewswire
·
May 5, 2025
PRESS RELEASE AB SCIENCE TO PRESENT NEW DATA FROM MASITINIB CLINICAL PROGRAM IN AMYOTROPHIC LATERAL SCLEROSIS IN TWO PRESENTATIONS AT THE 2025 ENCALS ANNUAL MEETING MASITINIB REDUCES SERUM NEUROFILAMENT LIGHT CHAIN (NFL) LEVELS, SUGGESTING THAT IT HAS …